Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Joanna Hockenhull, David M. Wood & Paul I. Dargan. (2020) The Availability of Modafinil and Methylphenidate Purchased from the Internet in the United Kingdom Without a Prescription. Substance Use & Misuse 55:1, pages 56-65.
Read now
Read now
Stephen J. Mounsey, Paul I. Dargan, Maryon Stewart, Andrew Brown, Nicola Newton & David M. Wood. (2016) Perceived risk of using novel psychoactive substances in school students: lower in users compared to non-users. Journal of Substance Use 21:3, pages 323-326.
Read now
Read now
Sindhu Siddiqi, Charlotte Verney, Paul Dargan & David M. Wood. (2015) Understanding the availability, prevalence of use, desired effects, acute toxicity and dependence potential of the novel opioid MT-45. Clinical Toxicology 53:1, pages 54-59.
Read now
Read now
Articles from other publishers (21)
Anand K. Gavai, Yamine Bouzembrak, Leonieke M. van den Bulk, Ningjing Liu, Lennert F.D. van Overbeeke, Lukas J. van den Heuvel, Hans Mol & Hans J.P. Marvin. (2021) Artificial intelligence to detect unknown stimulants from scientific literature and media reports. Food Control 130, pages 108360.
Crossref
Crossref
Hye Jin Cha, Jin Mook Kim, Young-Hsoon Kim & Soo Kyung Suh. (2019) Rewarding effects of 2-desoxypipradrol in mice. Neuroscience Letters 705, pages 46-50.
Crossref
Crossref
Andrew King, Mirjana Dimovska & Luke Bisoski. (2018) Sympathomimetic Toxidromes and Other Pharmacological Causes of Acute Hypertension. Current Hypertension Reports 20:1.
Crossref
Crossref
Bruno Ella, Imad Ghorayeb, Pierre Burbaud & Dominique Guehl. (2017) Bruxism in Movement Disorders: A Comprehensive Review. Journal of Prosthodontics 26:7, pages 599-605.
Crossref
Crossref
Yiu Cheung Chan, Chi Keung Chan, Chun Ho Ng, Sze Hong Ng, Kai Kee Lau & Man Li Tse. (2017) Hong Kong Poison Information Centre: Annual report 2016. Hong Kong Journal of Emergency Medicine 24:5, pages 244-254.
Crossref
Crossref
Noreen D Mdege, Nick Meader, Charlie Lloyd, Steve Parrott & Jim McCambridge. (2017) The Novel Psychoactive Substances in the UK Project: empirical and conceptual review work to produce research recommendations. Public Health Research 5:4, pages 1-138.
Crossref
Crossref
Odd Martin Vallersnes, Alison M. Dines, David M. Wood, Christopher Yates, Fridtjof Heyerdahl, Knut Erik Hovda, Isabelle Giraudon & Paul I. Dargan. (2016) Psychosis associated with acute recreational drug toxicity: a European case series. BMC Psychiatry 16:1.
Crossref
Crossref
David R. Owen, David M. Wood, John R. H. Archer & Paul I. Dargan. (2016) Phenibut (4-amino-3-phenyl-butyric acid): Availability, prevalence of use, desired effects and acute toxicity. Drug and Alcohol Review 35:5, pages 591-596.
Crossref
Crossref
D.M. Wood, B. Ceronie & P.I. Dargan. (2016) Healthcare professionals are less confident in managing acute toxicity related to the use of new psychoactive substances (NPS) compared with classical recreational drugs. QJM 109:8, pages 527-529.
Crossref
Crossref
Kathleen S Bonnici, Paul I Dargan & David M Wood. (2015) Novel psychoactive substances or ‘legal highs'. British Journal of Hospital Medicine 76:9, pages C130-C134.
Crossref
Crossref
James Glanville, Paul I. Dargan & David M. Wood. (2015) 4-Methyl-5-(4-methylphenyl)-4,5-dihydrooxazol-2-amine (4,4′-DMAR, 4,4′-dimethylaminorex): availability, prevalence of use, desired effects and acute toxicity. Human Psychopharmacology: Clinical and Experimental 30:3, pages 193-198.
Crossref
Crossref
Hisham Nizar, Paul I. Dargan & David M. Wood. (2014) Using Internet Snapshot Surveys to Enhance Our Understanding of the Availability of the Novel Psychoactive Substance 4-Methylaminorex and 4,4′-Dimethylaminorex. Journal of Medical Toxicology 11:1, pages 80-84.
Crossref
Crossref
Elena Durán, Marta Mosquera, Cristina Ruiz, Fernando Bandrés, Francesc Campos, Bartomeu Castanyer, Carme Farré, Juan Fernando Izquierdo, Elena Llorente, Jordi To-Figueras, Salvador Ventura & Josep M. Queraltó. (2015) Desoxipipradrol. Fármacos antiguos, problemas nuevos. Revista del Laboratorio Clínico 8:1, pages 29-38.
Crossref
Crossref
Jolanta B. Zawilska. 2015. The Neuropsychiatric Complications of Stimulant Abuse. The Neuropsychiatric Complications of Stimulant Abuse
273
300
.
Anders Helander, Matilda Bäckberg, Peter Hultén, Yasir Al-Saffar & Olof Beck. (2014) Detection of new psychoactive substance use among emergency room patients: Results from the Swedish STRIDA project. Forensic Science International 243, pages 23-29.
Crossref
Crossref
D. M. Wood, S. L. Hill, S. H. L. Thomas & P. I. Dargan. (2014) Using poisons information service data to assess the acute harms associated with novel psychoactive substances. Drug Testing and Analysis 6:7-8, pages 850-860.
Crossref
Crossref
Yasir Al-Saffar, Niclas Nikolai Stephanson & Olof Beck. (2013) Multicomponent LC–MS/MS screening method for detection of new psychoactive drugs, legal highs, in urine—Experience from the Swedish population. Journal of Chromatography B 930, pages 112-120.
Crossref
Crossref
Pirkko Kriikku, Lars Wilhelm, Janne Rintatalo, Jukka Hurme, Jan Kramer & Ilkka Ojanperä. (2013) Prevalence and blood concentrations of desoxypipradrol (2-DPMP) in drivers suspected of driving under the influence of drugs and in post-mortem cases. Forensic Science International 226:1-3, pages 146-151.
Crossref
Crossref
Markus R. Meyer, Tina Orschiedt & Hans H. Maurer. (2013) Michaelis–Menten kinetic analysis of drugs of abuse to estimate their affinity to human P-glycoprotein. Toxicology Letters 217:2, pages 137-142.
Crossref
Crossref
Markus R. Meyer, Sara Schmitt & Hans H. Maurer. (2013) Studies on the metabolism and detectability of the emerging drug of abuse diphenyl‐2‐pyrrolidinemethanol (D2PM) in rat urine using GC‐MS and LC‐HR‐MS/MS. Journal of Mass Spectrometry 48:2, pages 243-249.
Crossref
Crossref
Michael W. White & John R.H. Archer. 2013. Novel Psychoactive Substances. Novel Psychoactive Substances
233
259
.